On this page
What each program costs in South Carolina
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 15 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 16 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 17 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 18 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does South Carolina Medicaid cover GLP-1s for weight loss?
Wegovy no, Zepbound not confirmed
South Carolina Medicaid removed GLP-1 medications for obesity from its preferred drug list on December 31, 2025, and Wegovy stays covered only for other uses; no state document we could read names Zepbound. Read from state documents Nov 6, 2026.
What South Carolina Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. South Carolina Department of Health and Human Services.
WegovyNo
Still covered for uses other than obesity, such as heart risk or MASH, which may need a new prior authorization.
“GLP-1 medications for obesity would be removed from the PDL 12/31/2025.”
SCDHHS P&T Committee minutes · Effective Dec 31, 2025 · read Nov 6, 2026
“Wegovy will continue to be covered for indications other than obesity”
SCDHHS P&T Committee minutes · Effective Dec 31, 2025 · read Nov 6, 2026
ZepboundNot confirmed
No state document read names Zepbound. The November 2025 minutes speak of GLP-1 medications for obesity without naming it, and the October 2026 PDL and GLP-1 criteria omit it, but absence is not a no. scdhhs.gov and its provider manual returned 403.
OzempicNo
Requires a documented type 2 diabetes diagnosis, with metformin and A1c requirements.
“Trulicity (dulaglutide) and Ozempic (semaglutide) for Diabetes”
Prime Therapeutics for SCDHHS · Effective Oct 1, 2026 · read Nov 6, 2026
“Documented diagnosis of T2DM”
Prime Therapeutics for SCDHHS · Effective Oct 1, 2026 · read Nov 6, 2026
MounjaroNo
Requires a documented type 2 diabetes diagnosis, with metformin and A1c requirements. Also needs a trial or failure of preferred products.
“Exenatide, Liraglutide, Mounjaro (tirzepatide), Soliqua (lixisenatide/insulin glargine), Victoza (liraglutide), Xultophy (liraglutide, insulin degludec)”
Prime Therapeutics for SCDHHS · Effective Oct 1, 2026 · read Nov 6, 2026
“The patient meets the criteria listed above.”
Prime Therapeutics for SCDHHS · Effective Oct 1, 2026 · read Nov 6, 2026
“Documented diagnosis of T2DM”
Prime Therapeutics for SCDHHS · Effective Oct 1, 2026 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from South Carolina Department of Health and Human Services documents. KFF's January 2026 map listed this program as not covered; the documents we read answer only part of the question.
- Dec 31, 2025 · Policy changeRemoved GLP-1 medications for obesity from the preferred drug list.
“GLP-1 medications for obesity would be removed from the PDL 12/31/2025.”
SCDHHS P&T Committee minutes · Effective Dec 31, 2025 · read Nov 6, 2026
Weight loss
Not covered in part, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
11,352 prescriptions
Ozempic and Mounjaro, 2025
43,822 prescriptions
Neighbours covering weight loss
1 of 2
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your South Carolina Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed South Carolina Medicaid as "not covered" for GLP-1s for obesity under fee-for-service. South Carolina covered GLP-1s for obesity in October 2025 and had ended that coverage by January 2026.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether South Carolina Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does South Carolina Medicaid pay for?
65,093 GLP-1 prescriptions in 2025, 31st of the 50 states and DC, with $64.9 million reimbursed before rebates. Counting the share other payers covered, $64.9 million.
Prescriptions, 2025
65,093
31st of 51
Medicaid paid
$64.9M
32nd of 51, before rebates
Per prescription
$997
$1,051 nationally
Weight-loss brands
17%
16th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. South Carolina is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 17% of South Carolina Medicaid's GLP-1 prescriptions in 2025 (11,352). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was South Carolina Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 35,293 | 54% | $33.6 million | $952 |
| Wegovyapproved for weight management | 9,911 | 15% | $12.7 million | $1,277 |
| Trulicity | 9,039 | 14% | $8.5 million | $936 |
| Mounjaro | 8,529 | 13% | $8.0 million | $942 |
| Zepboundapproved for weight management | 1,441 | 2.2% | $1.4 million | $983 |
| Rybelsus | 616 | 0.9% | $580,854 | $943 |
| Victoza | 141 | 0.2% | $87,826 | $623 |
| Liraglutide (generic) | 66 | 0.1% | $28,968 | $439 |
| Bydureon | 57 | 0.1% | $44,604 | $783 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in South Carolina?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 2 in South Carolina. The register does not say which, if any, supplies a program on this page.
- Medi-Fare Drug, Blacksburg. Registered since Dec 17, 2013; last FDA inspection Jun 6, 2025.
- Nephron Sterile Compounding Center, LLC (NSCC), West Columbia. Registered since Jul 15, 2014; last FDA inspection Aug 22, 2025.
On Medicare in South Carolina?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
South Carolina and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 2 states next to South Carolina covers GLP-1s for weight loss through Medicaid: North Carolina. None has a lower cash floor than South Carolina's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| South Carolina | Not covered in part | 18 | $39/mo |
| Georgia | Not covered | 18 | $39/moWellmedr |
| North Carolina | Covered | 19 | $39/moWellmedr |





















